FIASP

This brand name is authorized in Albania, Austria, Australia, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Croatia, Ireland, Japan, Lithuania, Netherlands, Poland, Romania, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug FIASP contains one active pharmaceutical ingredient (API):

1 Insulin aspart UNII D933668QVX - INSULIN ASPART

The blood glucose lowering effect of insulin aspart is due to the facilitated uptake of glucose following binding of insulin to receptors on muscle and fat cells and to the simultaneous inhibition of glucose output from the liver. Insulin aspart produces a more rapid onset of action compared to soluble human insulin, together with a lower glucose concentration, as assessed within the first four hours after a meal. Insulin aspart has a shorter duration of action compared to soluble human insulin after subcutaneous injection. Read about Insulin aspart

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10AB05	Insulin aspart	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AB Insulins and analogues for injection, fast-acting
Discover more medicines within A10AB05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AL	Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor	Identifier(s): 446/93a
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11705C, 11706D
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 526618120010007, 526618120010107, 526619110007607, 526619110007707, 526619110007807
Country: CA	Health Products and Food Branch	Identifier(s): 02460408, 02460416, 02460424
Country: EE	Ravimiamet	Identifier(s): 1736906, 1736917, 1736928, 1736940, 1736951, 1736962, 1736973, 1736984, 1829965, 1829976
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1161160001, 1161160007, 1161160010, 1161160012
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 066518, 178981, 435387, 472559
Country: FR	Base de données publique des médicaments	Identifier(s): 60810891, 64366900, 65741417, 68772407
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 340431, 340433, 340435
Country: IE	Health Products Regulatory Authority	Identifier(s): 43903, 43911, 43918, 43919
Country: JP	医薬品医療機器総合機構	Identifier(s): 2492415A5026, 2492415A6022, 2492415G7021
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1081965, 1081966, 1081967, 1081968, 1081969, 1081970, 1081972, 1081973, 1081974, 1081975, 1081976, 1090529, 1090530
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 121355, 121495, 53880, 53902
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100380382
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W63975001, W63975002, W63975003, W63975004, W63975005, W63975006, W63976001, W63976002, W63977001, W63977002, W63977003
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699676950256, 8699676950263, 8699676950270, 8699676950287, 8699676950294
Country: US	FDA, National Drug Code	Identifier(s): 0169-3201, 0169-3204, 0169-3205
Country: ZA	Health Products Regulatory Authority	Identifier(s): 51/21.1/0733